Neurizon Therapeutics LimitedASX: NUZ

Final MND Patient in Cohort 4 Successfully Completes Dosing

· Issued by Neurizon Therapeutics Limited

Filed with ASX · · 3 pages · English

Neurizon Therapeutics Limited has released a press release.

View Attachment

6ix is checking which company filed this.

Neurizon Therapeutics Limited on 6ix

Story so far

Earlier from Neurizon Therapeutics

Later from Neurizon Therapeutics

All Neurizon Therapeutics news releases